B-Cell CLL/Lymphoma 2来源:原核表达宿主:E.coli内毒素水平:<1.0EU/µg(LAL法测定)亚细胞定位:外泌体预测分子量:26.7kDa实际分子量:26kDa(差异分析请参阅说明书)片段与标签:Ala2~Asp211 with N-terminal His Tag缓冲液成份:20mM Tris, 150mM NaCl, pH8.0, containing 0.01% SKL, 5% Trehalose.性状:冻干...
The past two decades have seen a major progress in the filed of pathphysiology and treatment ofchronic lymphocytic leukemia (CLL). New findings suggested that CLL comprises two separate typesof tumor with different prognosis outcome. CLL formerly was considered an incurable ''oldman'sdisease'' ...
B-cell CLL/lymphoma 2doi:10.1007/978-3-642-16483-5_547BCL2Springer Berlin Heidelberg
英文名称: Recombinant B-Cell CLL/Lymphoma 11A (Bcl11 英文同义词: Recombinant B-Cell CLL/Lymphoma 11A (Bcl11 CAS号: 分子式: 分子量: 0 EINECS号: 信息错误报告 您的Email: 按国家浏览Recombinant B-Cell CLL/Lymphoma 11A (Bcl11国外供应商 中国供应商 Recombinant B-Cell CLL/Lymphoma 11A (Bc...
B cell CLL/lymphoma 6 member B (BCL6B) is a novel tumor suppressor silenced in human cancer. In this study, we investigated the functional role and underlying mechanisms of BCL6B in hepatocellular carcinoma (HCC). BCL6B was expressed in normal HCC tissues, but its expression was suppressed...
Significant familial aggregation of CLL and B-cell lymphoproliferative d... JF Fraumeni,CL Vogel,VT Devita - 《Annals of Internal Medicine》 被引量: 82发表: 1969年 Intracellular T cell cytokines in patients with B cell chronic lymphocytic leukaemia (B-CLL) Abstract: Analysis of cytokine ...
(CCND1) and B-Cell CLL/lymphoma 2 (BCL2) Received: 25 March 2004 / Accepted: 15 May 2004 / Published online: 22 July 2004 Ó The Japan Society of Human Genetics and Springer-Verlag 2004 Abstract CCND1 is an important cell-cycle regulatory protein associated with cell proliferation, poor...
Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL Adam S. Kittai Ying Huang Jennifer A. Woyach CorrespondenceOpen Access20 Feb 2025Blood Cancer Journal Volume: 15, P: 23 Adding brentuximab vedotin to lenalidomide and rituximab improves OS in R/...
In patients with B-cell chronic lymphocytic leukemia (B-CLL), the absolute number of T cells is increased. Although it has been suggested that these T cells might be tumor specific, concrete evidence for this hypothesis is lacking. We performed a detailed immunophenotypic analysis of the T-cel...
Hui PK, Feller AC, Pileri S, Gobbi M, Lennert K (1987) New aggressive variant of suppressor/cytotoxic T-CLL. Am J Clin Pathol 87:55–59 PubMedCASGoogle Scholar Hui PK, Feller AC, Lennert K (1988) High grade non-Hodgkin’s lymphoma of B-cell type. I. Histopathology. Histopathology ...